Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines

被引:6
|
作者
Cheeseman, Matthew D. [1 ]
Faisal, Amir [1 ]
Rayter, Sydonia [1 ]
Barbeau, Olivier R. [1 ]
Kalusa, Andrew [1 ]
Westlake, Maura [1 ]
Burke, Rosemary [1 ]
Swan, Michael [1 ]
van Montfort, Rob [1 ]
Linardopoulos, Spiros [1 ]
Jones, Keith [1 ]
机构
[1] Inst Canc Res, CRUK Canc Therapeut Unit, London SM2 5NG, England
关键词
PPM1D; Phenotype; Apoptosis; p53; 2,4-Bisarylthiazole; BREAST-CANCER; INHIBITOR; ASSAY; WIP1; AMPLIFICATION; PHOSPHATASES; DISCOVERY;
D O I
10.1016/j.bmcl.2014.05.067
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The metal-dependent phosphatase PPM1D (WIP1) is an important oncogene in cancer, with over-expression of the protein being associated with significantly worse clinical outcomes. In this communication we describe the discovery and optimization of novel 2,4-bisarylthiazoles that phenocopy the knockdown of PPM1D, without inhibiting its phosphatase activity. These compounds cause growth inhibition at nanomolar concentrations, induce apoptosis, activate p53 and display impressive cell-line selectivity. The results demonstrate the potential for targeting phenotypes in drug discovery when tackling challenging targets or unknown mechanisms. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:3469 / 3474
页数:6
相关论文
共 50 条
  • [1] A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
    S Rayter
    R Elliott
    J Travers
    M G Rowlands
    T B Richardson
    K Boxall
    K Jones
    S Linardopoulos
    P Workman
    W Aherne
    C J Lord
    A Ashworth
    Oncogene, 2008, 27 : 1036 - 1044
  • [2] A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
    Rayter, S.
    Elliott, R.
    Travers, J.
    Rowlands, M. G.
    Richardson, T. B.
    Boxall, K.
    Jones, K.
    Linardopoulos, S.
    Workman, P.
    Aherne, W.
    Lord, C. J.
    Ashworth, A.
    ONCOGENE, 2008, 27 (08) : 1036 - 1044
  • [3] Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
    S. Rayter
    R. Elliott
    J. Travers
    M. G. Rowlands
    T. B. Richardson
    K. Boxall
    K. Jones
    S. Linardopoulos
    P. Workman
    W. Aherne
    C. J. Lord
    A. Ashworth
    Oncogene, 2020, 39 : 4780 - 4780
  • [4] A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D (vol 27, pg 1036, 2008)
    Rayter, S.
    Elliott, R.
    Travers, J.
    Rowlands, M. G.
    Richardson, T. B.
    Boxall, K.
    Jones, K.
    Linardopoulos, S.
    Workman, P.
    Aherne, W.
    Lord, C. J.
    Ashworth, A.
    ONCOGENE, 2020, 39 (24) : 4780 - 4780
  • [5] PPM1D Truncating Mutations Confer Chemotherapy Resistance in Hematopoietic Stem Cells, Which Is Reversible By PPM1D Inhibition
    Kahn, Josephine
    Silver, Alexander J.
    Mertins, Philipp
    Carr, Steven
    Jaiswal, Siddhartha
    Ebert, Benjamin L.
    BLOOD, 2016, 128 (22)
  • [6] PPM1D Mutations in Patients with Hematolymphoid Neoplasms
    Streich, Lukas
    Fisher-Campbell, Nora
    Magallanes-Hoyos, M. Cristina
    Gandhi, Arpita
    Li, Peng
    Wang, Sa
    Tang, Guilin
    Wang, Wei
    Wiszniewska, Joanna
    Dunlap, Jennifer
    Raess, Phil
    Williams, Todd
    Press, Richard
    Fan, Guang
    Xie, Wei
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1244 - S1245
  • [7] Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms
    Marcellino, Bridget
    Tripodi, Joseph
    Bar-Natan, Michal
    Fruchtman, Harry
    Farnoud, Noushin
    Lu, Min
    Kosiorek, Heidi E.
    Dueck, Amylou C.
    Rampal, Raajit K.
    Mascarenhas, John
    Najfeld, Vesna
    Hoffman, Ronald
    BLOOD, 2019, 134
  • [8] The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
    Kojima, Kensuke
    Maeda, Aya
    Yoshimura, Mariko
    Nishida, Yuki
    Kimura, Shinya
    ONCOTARGET, 2016, 7 (43) : 69625 - 69637
  • [9] Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation
    Ogasawara, Sari
    Kiyota, Yuhei
    Chuman, Yoshiro
    Kowata, Ayano
    Yoshimura, Fumihiko
    Tanino, Keiji
    Kamada, Rui
    Sakaguchi, Kazuyasu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (19) : 6246 - 6249
  • [10] PPM1D/WIP1, a potential target in neuroblastoma
    Milosevic, Jelena
    Wickstrom, Malin
    Treis, Diana
    Nordegren, Hjalmar Stahlberg
    Elfman, Lotta
    Baryawno, Ninib
    Fransson, Susanne
    Sveinbjornsson, Baldur
    Martinsson, Tommy
    Johnsen, John Inge
    Kogner, Per
    CANCER RESEARCH, 2014, 74 (19)